C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
167/208, 260/300
C07D 209/22 (2006.01) C07D 209/18 (2006.01) C07D 231/56 (2006.01) C07D 235/04 (2006.01) C07D 241/42 (2006.01) C07D 249/18 (2006.01) C07D 265/36 (2006.01) C07D 333/60 (2006.01) C07D 403/10 (2006.01)
Patent
CA 1336192
This invention provides a series of novel heterocyclic amides of Formula I Image I in which the group >X-Y-z< is selected from >C=CH-N<, >C=N-N<, >N-(CH2)-N<, >CH-CH2-N< and >N-N=C< and the other radicals have meanings defined, for example, wherein: A is a direct link when Z is nitrogen & A is oxygen when Z is carbon: R1 is an optionally substituted alkyl group; Ra is hydrogen or methyl: Rc is selected from a group consisting of hydrogen and alkoxy; Rd is hydrogen, cycloalkyl, cycloalkyl-alkyl or alkyl optionally containing one or two double or triple bonds, said alkyl additionally optionally bearing a substitutent P selected from a group consisting of cyano, carboxy, 1H-tetrazol-5-yl, alkoxycarbonyl, carbamoyl, ureido, carbamoyloxy, acylamino, acyloxy, and an optionally substituted alkyl or phenyl (optionally oxidized) thio group: and M is an acidic group selected from a group consisting of carboxy, an acylsulphonamide residue and 1H-tetrazol-5-yl. The compounds of formula I are useful in the treatment of, for example, allergic or inflammatory diseases, or endotoxic or traumatic shock conditions. The invention also provides pharmaceutical compositions containing the formula I compounds, or their salts, and processes for the manufacture of the formula I compounds.
520794
Bernstein Peter Robert
Brown Frederick Jeffrey
Giulio Matassa Victor
Yee Ying Kwong
Marks & Clerk
Zeneca Inc.
LandOfFree
Pharmaceutical benzoheterocyclylcarboxamide derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical benzoheterocyclylcarboxamide derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical benzoheterocyclylcarboxamide derivatives will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1216111